Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Cash & Equivalents history
Currency unavailable · from the balance sheet
No Cash & Equivalents data reported for this period type.
Cash & Equivalents vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
LBRXLB Pharmaceuticals Inc Common Stock | Mar 2026 | $320.68M USD | +2154.3% | +126.9% | 81.5% |
| Mar 2026 | $242.65M USD | -0.9% | +14.1% | 88.2% | |
NMRANeumora Therapeutics, Inc. Common Stock | Mar 2026 | $147.07M USD | +15.9% | -8.8% | 95.6% |
RAPPRapport Therapeutics, Inc. Common Stock | Mar 2026 | $78.06M USD | +35.5% | +19.1% | 15.7% |
| Mar 2026 | $55.71M USD | +11.1% | +19.1% | 13.3% | |
| Mar 2026 | $54.03M USD | -51.7% | -14.3% | 12.5% | |
CTNMContineum Therapeutics, Inc. Class A Common Stock | Mar 2026 | $20.16M USD | -10.3% | +138.6% | 7.7% |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | +11.1% | +19.1% | 15.7% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.